Elevance Health (ELV) Cash from Investing Activities (2010 - 2026)

Elevance Health (ELV) has reported Cash from Investing Activities for 17 consecutive years, with $159.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Investing Activities rose 123.14% year-over-year to $159.0 million; the TTM figure through Jun 2026 stood at -$2.2 billion (up 14.49% YoY), while the FY2025 annual figure was -$1.3 billion, up 73.99% from the prior year.
• Cash from Investing Activities improved to $159.0 million in Q2 2026 per ELV's latest filing, from -$1.6 billion in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $464.0 million in Q4 2025 and bottomed at -$3.2 billion in Q1 2023.
• Historically, Cash from Investing Activities has averaged -$1.0 billion across 5 years, with a median of -$923.5 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities soared 129.92% — and 2026, when it sank 1694.17%.
• Elevance Health's Cash from Investing Activities stood at $289.0 million in 2022, then sank by 456.06% to -$1.0 billion in 2023, then sank by 59.18% to -$1.6 billion in 2024, then surged by 128.33% to $464.0 million in 2025, then plunged by 65.73% to $159.0 million in 2026.
• Business Quant data shows ELV's Cash from Investing Activities at $159.0 million in Q2 2026, -$1.6 billion in Q1 2026, and $464.0 million in Q4 2025.